Camber Capital Management’s Pediatrix Medical MD Stock Holding History

Camber Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-790,000	Closed	-$22M	–	32
2019 Q4	$22M	Buy	+790,000	New	+$19.8M	1.12%	24

Other funds holding MD

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Camber Capital Management's MD Position: Q1 2020 in Review

Camber Capital Management sold out of Pediatrix Medical (MD) in Q1 2020, closing a stake of 790,000 shares — an estimated $22M sold.

Camber Capital Management first reported a position in MD in Q4 2019 and held it in 1 quarter. The position peaked at $22M in Q4 2019. 221 funds tracked by Wall St. Rank hold MD as of Q1 2020.

Camber Capital Management reported no remaining Pediatrix Medical position as of Q1 2020 after selling out during the quarter.
Camber Capital Management sold 790,000 Pediatrix Medical shares in Q1 2020, an estimated $22M.
Camber Capital Management first reported a position in Pediatrix Medical in Q4 2019 and held it in 1 quarter.
Camber Capital Management's Pediatrix Medical position peaked at $22M in Q4 2019.
221 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2020.

Based on Camber Capital Management's 13F filing for Q1 2020, filed 15 May 2020.